A Day in the Life of a Microbiology Biomedical Scientist UK 2026

Microbiology biomedical science combines bacteriology, virology, parasitology, and mycology to diagnose infections and guide antimicrobial treatment. This hour-by-hour account follows a typical day shift in a district general hospital microbiology department, revealing the diagnostic detective work that defines this specialty.

08:00 - Morning Arrival and Handover

I arrive at the microbiology lab for my 08:00-16:00 shift. The department is divided into sections: bacteriology (largest), virology/serology, mycobacteriology (TB lab - separate containment suite), and parasitology (limited, mostly sent to reference labs).

Handover from on-call BMS:

The weekend on-call biomedical scientist, Tom, provides the handover:

> "Morning! Busy weekend. We've got 12 blood cultures positive from Friday evening still needing subculture and identification this morning. Two are already Gram-stained - one Gram-positive cocci in clusters (likely Staph aureus), one Gram-negative rods (could be E. coli or similar). There's also a CSF from Saturday that grew on chocolate agar overnight - needs urgent Gram stain and ID. Everything else is routine. MALDI-TOF is working fine, no issues with incubators. Over to you."

My priorities today:

1. Process positive blood cultures (potential sepsis cases - urgent)

2. CSF culture follow-up (meningitis investigation - critical)

3. Read Friday's routine cultures (24-hour incubation complete)

4. Process today's new specimens as they arrive

08:15 - Blood Culture Processing (Urgent)

Blood cultures are among the most clinically significant specimens in microbiology. A positive blood culture = bacteraemia/sepsis = immediate clinical action needed.

Sample 1: Positive blood culture from 72-year-old on ICU

I retrieve the blood culture bottle from the BacT/ALERT automated system. The bottle flagged positive Friday evening after 18 hours incubation.

Gram stain (already performed by weekend staff):

• Result: Gram-positive cocci in clusters

• Preliminary interpretation: Staphylococcus species (likely S. aureus or coagulase-negative Staph)

My actions:

1. Subculture onto plates:

- Blood agar (general growth medium)

- Chocolate agar (fastidious organisms)

- Incubate at 37�C for 24 hours

2. Set up rapid tests:

- Catalase test: Positive (confirms Staphylococcus genus)

- Coagulase test (tube method): Set up, results in 4 hours

- If coagulase-positive = Staph aureus (more significant, potential MRSA)

- If coagulase-negative = Less virulent, possible contaminant

3. MALDI-TOF identification (if enough growth):

- Not enough colonies yet - will do after today's incubation

Preliminary report entered into LIMS:

> "Gram-positive cocci in clusters isolated. Identification and sensitivities to follow."

I call ICU to give verbal preliminary results:

> "This is microbiology calling about blood culture for patient bed 4. We've isolated Gram-positive cocci in clusters, likely Staphylococcus. We're working on full identification and antibiotic sensitivities - results tomorrow. The patient should be on appropriate empirical antibiotics already, but please ensure they're covered for Staph."

Sample 2: Positive blood culture - Gram-negative rods

Following the same process:

• Gram stain confirmed: Gram-negative rods

• Preliminary: Likely E. coli, Klebsiella, or other Enterobacterales

• Subculture onto: Blood agar, MacConkey agar (selective for Gram-negatives), CLED agar

• Preliminary report issued and medical team called

These urgent blood cultures will be my priority for full identification tomorrow when growth appears on the subculture plates.

09:00 - CSF Culture Follow-Up (Critical)

A cerebrospinal fluid (CSF) sample from Saturday's emergency meningitis investigation grew overnight on chocolate agar. This is critical - bacterial meningitis is life-threatening.

Clinical details: "3-year-old child, fever, neck stiffness, ?meningitis"

Culture results:

• Blood agar: No growth

• Chocolate agar: Small grey colonies (typical of Neisseria meningitidis or Haemophilus influenzae)

• MacConkey: No growth (rules out coliforms)

Gram stain of colony:

• Gram-negative diplococci (paired cocci)

• Immediate interpretation: Neisseria meningitidis (meningococcus) - medical emergency

Confirmatory tests:

1. Oxidase test: Positive (supports Neisseria)

2. API NH strip (biochemical identification): Set up for 2-hour incubation

3. Subculture for antibiotic sensitivities

Immediate action:

I call the consultant microbiologist directly (don't wait):

> "Dr. Patel, we have positive CSF culture from the 3-year-old ?meningitis from Saturday. Gram-negative diplococci, oxidase positive, growing on chocolate agar. Looks like Neisseria meningitidis. Awaiting API confirmation but thought you should know immediately."

Dr. Patel: "Excellent, thank you. I'll inform paediatrics. The child is already on IV ceftriaxone thankfully. Please expedite the sensitivities and let me know when you have serotyping."

Further actions:

• Send colony to reference lab for serotyping (meningococcus serogroup identification)

• Set up antibiotic sensitivity testing (Etest method for accurate MICs)

• Document in portfolio (critical diagnostic case)

This is why microbiology matters - we provide definitive diagnosis that guides life-saving treatment.

09:30 - Routine Culture Reading (Friday's Specimens)

Friday's routine specimens have now incubated for 72 hours (cultures read at 24h and 48h already by weekend staff, I'm doing final 72h read before discarding negative cultures).

Urine cultures (most common specimen type):

Sample 1: 45-year-old female, GP referral, ?UTI

• CLED agar: Heavy pure growth of lactose-fermenting colonies

• Colony count: >10u CFU/mL (significant bacteriuria)

• Identification needed

I pick a colony for MALDI-TOF identification:

1. Apply colony to MALDI target plate

2. Add matrix solution

3. Insert into MALDI-TOF mass spectrometer

4. Result in 2 minutes: Escherichia coli (99.9% confidence)

Antibiotic sensitivity testing:

• Set up disc diffusion method on Mueller-Hinton agar

• Antibiotics tested: Trimethoprim, Nitrofurantoin, Cefalexin, Co-amoxiclav, Ciprofloxacin

• Incubate 18 hours, read tomorrow

Result entered:

> "Escherichia coli >10u CFU/mL. Antibiotic sensitivities to follow."

Sample 2: 68-year-old male, catheterized, ?UTI

• CLED agar: Mixed growth of 3 different colony types

• Interpretation: Contaminated specimen or colonization (not infection)

• Result: "Mixed growth of skin/bowel flora. Not significant. Please repeat MSU if UTI still suspected clinically."

I process 15 more urine cultures - 8 negative (no significant growth), 5 E. coli, 1 Klebsiella pneumoniae, 1 mixed flora.

Wound swabs:

Sample 1: Leg ulcer swab, 75-year-old

• Heavy growth Staphylococcus aureus

• MALDI-TOF confirms identification

• Set up antibiotic sensitivities including MRSA screen (cefoxitin disc)

Sample 2: Surgical wound swab

• Heavy growth Pseudomonas aeruginosa (blue-green colonies on blood agar - characteristic)

• This organism is intrinsically resistant to many antibiotics

• Set up extended sensitivity panel

10:30 - Respiratory Specimens

Sputum sample: 65-year-old with chronic cough, ?TB

This goes to the mycobacteriology lab (separate containment level 3 facility), but I receive the initial report:

• Ziehl-Neelsen stain: No acid-fast bacilli seen (negative for TB on microscopy)

• Culture set up (Mycobacterial cultures take 6 weeks to grow)

Sputum sample: ?Pneumonia

• Gram stain: Numerous Gram-positive diplococci and polymorphs

• Culture: Heavy growth on blood agar, alpha-haemolytic colonies

• MALDI-TOF: Streptococcus pneumoniae (pneumococcus - commonest cause of bacterial pneumonia)

• Optochin sensitivity test: Positive (confirms S. pneumoniae)

• Set up antibiotic sensitivities

11:00 - MRSA Screening Samples

We process 20 MRSA screening swabs daily (nose/throat/groin swabs from patients being admitted to high-risk wards).

Process:

1. Inoculate onto MRSA chromogenic agar (selective medium - MRSA grows blue colonies)

2. Incubate 24 hours

3. Read tomorrow

Today I'm reading yesterday's MRSA screens:

Results:

• 18 negative (no MRSA)

• 2 positive (blue colonies growing)

Positive samples - confirmation required:

• MALDI-TOF identification: Staphylococcus aureus

• Cefoxitin disc test: Resistant (confirms MRSA)

Action:

Report MRSA positive to infection control team immediately:

> "Two new MRSA isolates: Patient A (orthopaedic ward) and Patient B (medical ward). Isolates confirmed as meticillin-resistant Staphylococcus aureus. Sensitivities to follow."

Infection control will implement isolation precautions for these patients.

11:30 - Stool Specimens (Gastroenteritis Investigation)

Sample 1: 4-year-old with diarrhoea and vomiting

• Inoculated onto: XLD agar (Salmonella/Shigella selective), CCDA (Campylobacter selective), MacConkey (coliforms)

• Incubate: XLD/MacConkey at 37�C, CCDA in microaerophilic conditions at 42�C

• Results tomorrow

*Sample 2: Suspected Clostridioides difficile infection (hospital-acquired diarrhoea)

• Send for C. difficile toxin PCR test (molecular lab does this)

2. Interpretation: Likely Staphylococcus aureus septic arthritis

3. Culture: Inoculate blood agar, chocolate agar, enrichment broth

4. Immediate call to orthopaedics:

> "Joint aspirate from patient X shows Gram-positive cocci in clusters with heavy pus cells. Strongly suggestive of staphylococcal septic arthritis. Culture and sensitivities to follow but please ensure patient on appropriate IV antibiotics."

The remaining specimens are processed systematically using standard protocols.

13:30 - Antibiotic Sensitivity Reading (Yesterday's Cultures)

Yesterday's cultures now have antibiotic sensitivity results ready to read. I use callipers to measure inhibition zones around antibiotic discs.

Example: E. coli from urine

Disc diffusion zones measured and interpreted using EUCAST guidelines:

• Trimethoprim: 8mm (Resistant)

Report issued:

> "Escherichia coli >10u CFU/mL

> Sensitive to: Nitrofurantoin, Cefalexin, Ciprofloxacin

> Resistant to: Trimethoprim, Co-amoxiclav"

I process sensitivities for 15 organisms, entering results into LIMS for reporting to clinicians.

14:00 - Virology/Serology Samples

Our virology section processes mainly serology (antibody detection) and sends swabs to reference labs for viral PCR.

Today's samples:

• HIV serology: 3 samples (automated ELISA)

• Positive control: E. coli grows on MacConkey (confirms media viable)

> "That's the Staphylococcus aureus from yesterday. Sensitivities are reading now - it's meticillin-sensitive (MSSA), and it's sensitive to flucloxacillin, co-amoxiclav, and gentamicin. Resistant to penicillin as expected."

Dr. Patel: "Perfect, we'll switch from empirical vancomycin to flucloxacillin. Thanks!"

These real-time interactions guide antimicrobial stewardship - using the most appropriate antibiotic based on our lab results.

15:30 - Result Authorization and Reporting

I review all completed results before final authorization:

Today's finalized reports:

• 23 urine cultures (15 negative, 8 with identified organisms and sensitivities)

• 1 CSF culture (Neisseria meningitidis confirmed)

Quality check: I review unusual results or significant pathogens with my supervisor before authorization. Today's N. meningitidis CSF culture was reviewed and authorized by the consultant microbiologist.

16:00 - End of Shift Handover

I prepare handover for the late shift:

Written handover log:

• 12 blood cultures from today need subculture and ID tomorrow morning

• CSF N. meningitidis sent to reference lab for serotyping - chase result tomorrow

• CSF N. meningitidis case documented (excellent clinical decision-making evidence)

I also update my CPD log with today's learning: refreshed knowledge on Neisseria meningitidis identification and public health implications.

Reflections on the Day

What I loved:

• The CSF meningococcus diagnosis - directly impacting patient treatment

This account reflects a typical day for a Band 6 microbiology biomedical scientist at a UK district general hospital in 2026. Individual experiences vary by trust size, specimen volume, and department structure.

Salary figures based on NHS England 2026/27 Agenda for Change pay scales. NHS Scotland rates differ significantly: Band 5: £33,247-£41,424, Band 6: £41,608-£50,702, Band 7: £50,861-£59,159, Band 8a: £62,681-£67,665.*